Molecular biology of gliomas: present and future challenges
- PMID: 25147764
- PMCID: PMC4140427
Molecular biology of gliomas: present and future challenges
Abstract
Malignant brain tumours are one of the most relevant causes of morbidity and mortality across a wide range of individuals. Malignant glioma is the most common intra axial tumor in the adult. Many researches on this theme brought advances in the knowledge of gliomas biology and pathogenesis and to the development of new agents for targeted molecular therapy. Recent studies focused on either tumor metabolism analysis or epigenetic regulation in the pathogenesis or maintenance of brain tumors. This Review summarizes these developments analyzing molecular pathology and possible further developments for targeted therapies.
Keywords: IDH; genetics; glioma; metilation; therapy.
References
-
- Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK. Malignant astrocyticglioma: genetics, biology, and paths to treatment. Genes Dev. 2007 Nov 1;21(21):2683–710. - PubMed
-
- Preusser M, de Ribaupierre S, Wöhrer A, Erridge SC, Hegi M, Weller M, Stupp R. Current concepts and management of glioblastoma. Ann Neurol. 2011 Jul;70(1):9–21. - PubMed